SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1CA'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_A_STRA1_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 11 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80LEU A 111MET A 115CYH A 205THR A 208PHE A 219 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.60A | 1a28A-2q3yA:37.9 | 1a28A-2q3yA:63.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_A_STRA1_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80LEU A 111MET A 115CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)None1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.64A | 1a28A-3ry9A:36.7 | 1a28A-3ry9A:62.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | ASN A 33LEU A 35GLN A 39MET A 70ARG A 80LEU A 111MET A 115CYH A 205THR A 208 | 1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.73A | 1a28B-2q3yA:37.4 | 1a28B-2q3yA:63.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 10 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80MET A 115CYH A 205THR A 208 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.52A | 1a28B-2q3yA:37.4 | 1a28B-2q3yA:63.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35LEU A 32LEU A 29LEU A 77MET A 115 | 1CA A 247 ( 4.4A)1CA A 247 (-4.0A)1CA A 247 ( 3.6A)1CA A 247 ( 3.9A)1CA A 247 ( 3.7A) | 1.29A | 1a28B-2q3yA:37.4 | 1a28B-2q3yA:63.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80MET A 115CYH A 205THR A 208 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A) | 0.53A | 1a28B-3ry9A:36.6 | 1a28B-3ry9A:62.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80LEU A 111MET A 115CYH A 205THR A 208 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)None1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A) | 0.73A | 1a28B-3ry9A:36.6 | 1a28B-3ry9A:62.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 35LEU A 32LEU A 29LEU A 77MET A 115 | 1CA A 249 ( 4.4A)1CA A 249 (-3.9A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.6A) | 1.35A | 1a28B-3ry9A:36.6 | 1a28B-3ry9A:62.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERR_A_RALA600_1 (ESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ALA A 36TRP A 69LEU A 77ARG A 80MET A 108 | 1CA A 247 (-3.6A)None1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.88A | 1errA-2q3yA:24.9 | 1errA-2q3yA:26.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1G50_A_ESTA600_1 (ESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 11 | LEU A 32LEU A 35ALA A 36ARG A 80MET A 108 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.62A | 1g50A-2q3yA:28.1 | 1g50A-2q3yA:27.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1GS4_A_ZK5A1918_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39TRP A 69MET A 70MET A 108PHE A 219 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.9A)1CA A 247 (-4.5A) | 0.50A | 1gs4A-2q3yA:37.1 | 1gs4A-2q3yA:59.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1GS4_A_ZK5A1918_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | LEU A 32ASN A 33LEU A 35GLY A 36GLN A 39TRP A 69MET A 70MET A 108PHE A 219 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.6A)1CA A 249 (-4.3A) | 0.69A | 1gs4A-3ry9A:36.7 | 1gs4A-3ry9A:55.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GWR_A_ESTA600_1 (OESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 10 | LEU A 32LEU A 35ALA A 36LEU A 77ARG A 80 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 0.39A | 1gwrA-2q3yA:28.2 | 1gwrA-2q3yA:27.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | ASN A 33GLN A 39TRP A 69MET A 70ARG A 80CYH A 205THR A 208PHE A 219LEU A 223 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A)None | 0.55A | 1m2zA-2q3yA:36.5 | 1m2zA-2q3yA:62.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | ASN A 33GLN A 39TRP A 69MET A 70ARG A 80MET A 115CYH A 205THR A 208 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.70A | 1m2zA-2q3yA:36.5 | 1m2zA-2q3yA:62.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | ASN A 33GLY A 37TRP A 69CYH A 205THR A 208PHE A 219LEU A 223 | 1CA A 247 (-2.9A)NoneNone1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A)None | 0.93A | 1m2zA-2q3yA:36.5 | 1m2zA-2q3yA:62.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80CYH A 205THR A 208PHE A 219LEU A 223 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A)None | 0.44A | 1m2zA-3ry9A:35.8 | 1m2zA-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 115CYH A 205THR A 208LEU A 223 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)None | 0.67A | 1m2zA-3ry9A:35.8 | 1m2zA-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | ASN A 33GLY A 37GLN A 39TRP A 69MET A 70CYH A 205THR A 208PHE A 219LEU A 223 | 1CA A 249 (-3.0A)None1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A)None | 0.98A | 1m2zA-3ry9A:35.8 | 1m2zA-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | ASN A 33GLN A 39MET A 70ARG A 80CYH A 205THR A 208PHE A 219LEU A 223 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A)None | 0.50A | 1m2zD-2q3yA:36.2 | 1m2zD-2q3yA:62.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | ASN A 33GLN A 39MET A 70ARG A 80MET A 115CYH A 205THR A 208 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.73A | 1m2zD-2q3yA:36.2 | 1m2zD-2q3yA:62.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | ASN A 33GLY A 37CYH A 205THR A 208PHE A 219LEU A 223 | 1CA A 247 (-2.9A)None1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A)None | 0.82A | 1m2zD-2q3yA:36.2 | 1m2zD-2q3yA:62.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | ASN A 33GLY A 36GLN A 39MET A 70ARG A 80CYH A 205THR A 208PHE A 219LEU A 223 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A)None | 0.35A | 1m2zD-3ry9A:35.7 | 1m2zD-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | ASN A 33GLY A 36GLN A 39MET A 70ARG A 80MET A 115CYH A 205THR A 208LEU A 223 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)None | 0.69A | 1m2zD-3ry9A:35.7 | 1m2zD-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 219LEU A 223 | 1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A)None | 0.87A | 1m2zD-3ry9A:35.7 | 1m2zD-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | ASN A 33GLN A 39MET A 73LEU A 77ARG A 80MET A 115 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A) | 0.87A | 1nhzA-2q3yA:30.3 | 1nhzA-2q3yA:58.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | LEU A 32GLN A 39MET A 73LEU A 77ARG A 80MET A 115LEU A 201 | 1CA A 247 (-4.0A)1CA A 247 (-3.1A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A) | 0.57A | 1nhzA-2q3yA:30.3 | 1nhzA-2q3yA:58.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | ASN A 33GLY A 36GLN A 39MET A 73LEU A 77ARG A 80MET A 115 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 (-3.9A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A) | 0.92A | 1nhzA-3ry9A:29.8 | 1nhzA-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 12 | LEU A 32GLY A 36GLN A 39MET A 73LEU A 77ARG A 80MET A 115LEU A 201 | 1CA A 249 (-3.9A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 (-3.9A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A) | 0.64A | 1nhzA-3ry9A:29.8 | 1nhzA-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80MET A 115THR A 208 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 (-3.4A) | 0.86A | 1p93A-2q3yA:34.9 | 1p93A-2q3yA:58.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | LEU A 32ASN A 33LEU A 35GLY A 36GLN A 39MET A 70ARG A 80MET A 115THR A 208 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-3.2A) | 0.85A | 1p93A-3ry9A:35.2 | 1p93A-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | ASN A 33GLN A 39MET A 70LEU A 77ARG A 80MET A 115CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.68A | 1p93B-2q3yA:35.1 | 1p93B-2q3yA:58.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ASN A 33GLY A 37CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)None1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.93A | 1p93B-2q3yA:35.1 | 1p93B-2q3yA:58.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | ASN A 33GLY A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 115CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.67A | 1p93B-3ry9A:35.4 | 1p93B-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.04A | 1p93B-3ry9A:35.4 | 1p93B-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | ASN A 33GLN A 39MET A 70LEU A 77ARG A 80MET A 115LEU A 201CYH A 205THR A 208 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.82A | 1p93C-2q3yA:34.8 | 1p93C-2q3yA:58.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208 | 1CA A 247 (-2.9A)None1CA A 247 ( 3.8A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 1.20A | 1p93C-2q3yA:34.8 | 1p93C-2q3yA:58.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | ASN A 33GLY A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 115LEU A 201CYH A 205THR A 208 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-3.2A) | 0.78A | 1p93C-3ry9A:35.1 | 1p93C-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208 | 1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-4.0A)1CA A 249 (-3.2A) | 1.09A | 1p93C-3ry9A:35.1 | 1p93C-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | ASN A 33GLN A 39MET A 70ARG A 80PHE A 92MET A 115CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.80A | 1p93D-2q3yA:34.8 | 1p93D-2q3yA:58.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ASN A 33GLY A 37CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)None1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.94A | 1p93D-2q3yA:34.8 | 1p93D-2q3yA:58.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | ASN A 33GLY A 36GLN A 39MET A 70ARG A 80PHE A 92MET A 115CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)None1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.76A | 1p93D-3ry9A:35.2 | 1p93D-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.06A | 1p93D-3ry9A:35.2 | 1p93D-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 5 | LEU A 32TRP A 69MET A 73LEU A 77 | 1CA A 247 (-4.0A)None1CA A 247 (-3.6A)1CA A 247 ( 3.9A) | 0.77A | 1p93D-2q3yA:34.8 | 1p93D-2q3yA:58.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 5 | LEU A 32TRP A 69MET A 73LEU A 77 | 1CA A 249 (-3.9A)None1CA A 249 (-3.9A)1CA A 249 ( 4.1A) | 0.68A | 1p93D-3ry9A:35.2 | 1p93D-3ry9A:71.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QKN_A_RALA600_1 (ESTROGEN RECEPTORBETA) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 32ALA A 36MET A 70LEU A 77ARG A 80 | 1CA A 247 (-4.0A)1CA A 247 (-3.6A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 0.33A | 1qknA-2q3yA:25.4 | 1qknA-2q3yA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QKT_A_ESTA600_1 (ESTRADIOL RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 10 | LEU A 32ALA A 36LEU A 77ARG A 80MET A 108 | 1CA A 247 (-4.0A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.41A | 1qktA-2q3yA:24.5 | 1qktA-2q3yA:27.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9P_A_DESA459_1 (ESTROGEN-RELATEDRECEPTOR GAMMA) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 29LEU A 32ALA A 36MET A 70ARG A 80 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-3.6A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A) | 0.48A | 1s9pA-2q3yA:26.4 | 1s9pA-2q3yA:27.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9P_B_DESB459_1 (ESTROGEN-RELATEDRECEPTOR GAMMA) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 29LEU A 35ALA A 36MET A 70ARG A 80 | 1CA A 247 ( 3.6A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A) | 0.50A | 1s9pB-2q3yA:26.8 | 1s9pB-2q3yA:27.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9P_C_DESC500_1 (ESTROGEN-RELATEDRECEPTOR GAMMA) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 29LEU A 32LEU A 35ALA A 36MET A 70ARG A 80 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A) | 0.46A | 1s9pC-2q3yA:26.6 | 1s9pC-2q3yA:27.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9P_C_DESC500_1 (ESTROGEN-RELATEDRECEPTOR GAMMA) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 29LEU A 32LEU A 35MET A 70ARG A 80 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A) | 0.45A | 1s9pC-3ry9A:26.8 | 1s9pC-3ry9A:28.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9P_D_DESD600_1 (ESTROGEN-RELATEDRECEPTOR GAMMA) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 29LEU A 32ALA A 36MET A 70ARG A 80 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-3.6A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A) | 0.39A | 1s9pD-2q3yA:28.0 | 1s9pD-2q3yA:27.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9P_D_DESD600_1 (ESTROGEN-RELATEDRECEPTOR GAMMA) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 29LEU A 32MET A 70ARG A 80LEU A 111 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)None | 0.81A | 1s9pD-3ry9A:28.5 | 1s9pD-3ry9A:28.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 29ASN A 33MET A 70LEU A 111CYH A 205 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 ( 3.8A)None1CA A 247 (-4.0A) | 0.80A | 1sqnA-2q3yA:37.3 | 1sqnA-2q3yA:62.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73MET A 115CYH A 205 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A) | 0.39A | 1sqnA-2q3yA:37.3 | 1sqnA-2q3yA:62.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35LEU A 32LEU A 29LEU A 77MET A 115 | 1CA A 247 ( 4.4A)1CA A 247 (-4.0A)1CA A 247 ( 3.6A)1CA A 247 ( 3.9A)1CA A 247 ( 3.7A) | 1.22A | 1sqnA-2q3yA:37.3 | 1sqnA-2q3yA:62.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 29ASN A 33MET A 70LEU A 111CYH A 205 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)None1CA A 249 (-4.0A) | 0.84A | 1sqnA-3ry9A:36.4 | 1sqnA-3ry9A:61.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73MET A 115CYH A 205 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.6A)1CA A 249 (-4.0A) | 0.47A | 1sqnA-3ry9A:36.4 | 1sqnA-3ry9A:61.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 35LEU A 32LEU A 29LEU A 77MET A 115 | 1CA A 249 ( 4.4A)1CA A 249 (-3.9A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.6A) | 1.28A | 1sqnA-3ry9A:36.4 | 1sqnA-3ry9A:61.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 10 / 12 | LEU A 29ASN A 33LEU A 35GLN A 39MET A 70MET A 73LEU A 111MET A 115LEU A 201CYH A 205 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)None1CA A 247 ( 3.7A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A) | 0.69A | 1sqnB-2q3yA:37.5 | 1sqnB-2q3yA:62.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 10 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73MET A 115LEU A 201CYH A 205 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A) | 0.47A | 1sqnB-2q3yA:37.5 | 1sqnB-2q3yA:62.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 35LEU A 32LEU A 29LEU A 77MET A 115LEU A 90 | 1CA A 247 ( 4.4A)1CA A 247 (-4.0A)1CA A 247 ( 3.6A)1CA A 247 ( 3.9A)1CA A 247 ( 3.7A)None | 1.19A | 1sqnB-2q3yA:37.5 | 1sqnB-2q3yA:62.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 12 | LEU A 29ASN A 33GLN A 39MET A 70LEU A 111MET A 115LEU A 201CYH A 205 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)None1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A) | 0.79A | 1sqnB-3ry9A:36.9 | 1sqnB-3ry9A:61.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73MET A 115LEU A 201CYH A 205 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A) | 0.56A | 1sqnB-3ry9A:36.9 | 1sqnB-3ry9A:61.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | LEU A 35LEU A 32LEU A 29LEU A 77MET A 115LEU A 90 | 1CA A 249 ( 4.4A)1CA A 249 (-3.9A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.6A)None | 1.23A | 1sqnB-3ry9A:36.9 | 1sqnB-3ry9A:61.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_A_STRA1001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 28LEU A 35GLN A 39LEU A 77ARG A 80 | None1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 1.14A | 1ya3A-2q3yA:36.9 | 1ya3A-2q3yA:72.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_A_STRA1001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | LEU A 29ASN A 33LEU A 35ALA A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 108MET A 115CYH A 205THR A 208 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.48A | 1ya3A-2q3yA:36.9 | 1ya3A-2q3yA:72.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_A_STRA1001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 28LEU A 35GLN A 39LEU A 77ARG A 80 | None1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A) | 1.15A | 1ya3A-3ry9A:36.3 | 1ya3A-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_A_STRA1001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 29ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80MET A 108MET A 115CYH A 205THR A 208 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A) | 0.42A | 1ya3A-3ry9A:36.3 | 1ya3A-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_B_STRB2001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 11 / 12 | LEU A 29ASN A 33ALA A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 108LEU A 201CYH A 205THR A 208 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.50A | 1ya3B-2q3yA:37.1 | 1ya3B-2q3yA:72.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_B_STRB2001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 29ASN A 33LEU A 90LEU A 201CYH A 205THR A 208 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)None1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 1.30A | 1ya3B-2q3yA:37.1 | 1ya3B-2q3yA:72.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_B_STRB2001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 29ASN A 33GLN A 39MET A 70LEU A 77ARG A 80MET A 108LEU A 201CYH A 205THR A 208 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-3.2A) | 0.43A | 1ya3B-3ry9A:36.9 | 1ya3B-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_C_STRC3001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35ALA A 36GLN A 39MET A 70ARG A 80MET A 108LEU A 201CYH A 205THR A 208 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.56A | 1ya3C-2q3yA:36.9 | 1ya3C-2q3yA:72.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_C_STRC3001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80MET A 108LEU A 201CYH A 205THR A 208 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-3.2A) | 0.49A | 1ya3C-3ry9A:36.9 | 1ya3C-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z95_A_198A501_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 35GLN A 39MET A 70MET A 73ARG A 80ILE A 227 | 1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)None | 0.45A | 1z95A-2q3yA:37.0 | 1z95A-2q3yA:60.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z95_A_198A501_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | LEU A 35GLY A 36GLN A 39MET A 70MET A 73ARG A 80ILE A 227 | 1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)None | 0.59A | 1z95A-3ry9A:36.4 | 1z95A-3ry9A:54.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z95_A_198A501_2 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 6 | LEU A 32ASN A 33MET A 115LEU A 201 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A) | 0.88A | 1z95A-2q3yA:37.0 | 1z95A-2q3yA:60.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z95_A_198A501_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 6 | LEU A 32ASN A 33LEU A 201ILE A 226 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.2A)None | 0.57A | 1z95A-3ry9A:36.4 | 1z95A-3ry9A:54.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z95_A_198A501_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 6 | LEU A 32MET A 115LEU A 201ILE A 226 | 1CA A 249 (-3.9A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)None | 0.93A | 1z95A-3ry9A:36.4 | 1z95A-3ry9A:54.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_A_T98A201_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 10 | LEU A 29ASN A 33GLN A 39LEU A 77ARG A 80LEU A 111THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)None1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.63A | 1zucA-2q3yA:37.7 | 1zucA-2q3yA:63.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_A_T98A201_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 10 | LEU A 29ASN A 33GLN A 39MET A 73LEU A 77ARG A 80THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.40A | 1zucA-2q3yA:37.7 | 1zucA-2q3yA:63.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_A_T98A201_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 10 | LEU A 29ASN A 33LEU A 90LEU A 111THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)NoneNone1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.42A | 1zucA-2q3yA:37.7 | 1zucA-2q3yA:63.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_A_T98A201_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 10 | ASN A 33GLN A 39LEU A 77ARG A 80LEU A 111THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 (-3.0A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)None1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.73A | 1zucA-3ry9A:36.7 | 1zucA-3ry9A:62.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_A_T98A201_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 10 | LEU A 29ASN A 33GLN A 39MET A 73LEU A 77ARG A 80THR A 208PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 (-3.0A)1CA A 249 (-3.9A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.50A | 1zucA-3ry9A:36.7 | 1zucA-3ry9A:62.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_A_T98A201_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 10 | LEU A 29ASN A 33LEU A 90THR A 208PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)None1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.12A | 1zucA-3ry9A:36.7 | 1zucA-3ry9A:62.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 10 / 12 | ASN A 33LEU A 35GLN A 39MET A 70MET A 73LEU A 77ARG A 80LEU A 111THR A 208PHE A 219 | 1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)None1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.63A | 1zucB-2q3yA:37.3 | 1zucB-2q3yA:63.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 11 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73LEU A 77ARG A 80THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.47A | 1zucB-2q3yA:37.3 | 1zucB-2q3yA:63.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 29LEU A 32ASN A 33LEU A 90THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)None1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.23A | 1zucB-2q3yA:37.3 | 1zucB-2q3yA:63.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80LEU A 111THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)None1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.70A | 1zucB-3ry9A:36.5 | 1zucB-3ry9A:62.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73LEU A 77ARG A 80THR A 208PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.56A | 1zucB-3ry9A:36.5 | 1zucB-3ry9A:62.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | LEU A 29LEU A 32ASN A 33LEU A 90THR A 208PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)None1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.20A | 1zucB-3ry9A:36.5 | 1zucB-3ry9A:62.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_A_STRA301_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 11 / 12 | ASN A 33LEU A 35ALA A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 108MET A 115CYH A 205THR A 208 | 1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.40A | 2aa5A-2q3yA:38.5 | 2aa5A-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_A_STRA301_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80MET A 108MET A 115CYH A 205THR A 208 | 1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A) | 0.32A | 2aa5A-3ry9A:38.0 | 2aa5A-3ry9A:65.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 28LEU A 35GLN A 39LEU A 77ARG A 80 | None1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 1.28A | 2aa5B-2q3yA:38.6 | 2aa5B-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 11 / 12 | LEU A 29ASN A 33LEU A 35ALA A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 108CYH A 205THR A 208 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.40A | 2aa5B-2q3yA:38.6 | 2aa5B-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 29ASN A 33LEU A 90CYH A 205THR A 208 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)None1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 1.30A | 2aa5B-2q3yA:38.6 | 2aa5B-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 28LEU A 35GLN A 39LEU A 77ARG A 80 | None1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A) | 1.32A | 2aa5B-3ry9A:37.6 | 2aa5B-3ry9A:65.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 29ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80MET A 108CYH A 205THR A 208 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A) | 0.33A | 2aa5B-3ry9A:37.6 | 2aa5B-3ry9A:65.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_A_STRA401_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | LEU A 32ASN A 33LEU A 35ALA A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 108MET A 115CYH A 205THR A 208 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.36A | 2aa6A-2q3yA:38.5 | 2aa6A-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_A_STRA401_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80MET A 108MET A 115CYH A 205THR A 208 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A) | 0.26A | 2aa6A-3ry9A:37.6 | 2aa6A-3ry9A:65.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_B_STRB402_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | ASN A 33LEU A 35ALA A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 108MET A 115LEU A 201CYH A 205THR A 208 | 1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.35A | 2aa6B-2q3yA:38.4 | 2aa6B-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_B_STRB402_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80MET A 108MET A 115LEU A 201CYH A 205THR A 208 | 1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-3.2A) | 0.23A | 2aa6B-3ry9A:37.5 | 2aa6B-3ry9A:65.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ASN A 33PHE A 98CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)None1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.15A | 2ab2A-2q3yA:38.5 | 2ab2A-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 28GLN A 39ARG A 80PHE A 92MET A 115 | None1CA A 247 (-3.1A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A) | 1.48A | 2ab2A-2q3yA:38.5 | 2ab2A-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | LEU A 29ASN A 33ALA A 36GLN A 39MET A 70ARG A 80PHE A 92MET A 108MET A 115CYH A 205THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)None1CA A 247 (-3.9A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.38A | 2ab2A-2q3yA:38.5 | 2ab2A-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 29ASN A 33GLN A 39MET A 70ARG A 80PHE A 92MET A 108MET A 115CYH A 205THR A 208PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)None1CA A 249 (-3.6A)1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.33A | 2ab2A-3ry9A:37.8 | 2ab2A-3ry9A:65.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | LEU A 29PHE A 98MET A 108CYH A 205THR A 208PHE A 219 | 1CA A 249 ( 3.8A)None1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.40A | 2ab2A-3ry9A:37.8 | 2ab2A-3ry9A:65.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_2 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 6 | LEU A 32LEU A 35LEU A 77CYH A 112LEU A 201 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 ( 3.9A)None1CA A 247 ( 4.2A) | 0.19A | 2ab2A-2q3yA:38.5 | 2ab2A-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_2 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 6 | LEU A 32LEU A 35LEU A 77CYH A 112LEU A 201 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 ( 4.1A)None1CA A 249 ( 4.2A) | 0.18A | 2ab2A-3ry9A:37.8 | 2ab2A-3ry9A:65.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ASN A 33PHE A 98CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)None1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.16A | 2ab2B-2q3yA:38.4 | 2ab2B-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 28GLN A 39ARG A 80PHE A 92MET A 115 | None1CA A 247 (-3.1A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A) | 1.48A | 2ab2B-2q3yA:38.4 | 2ab2B-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | LEU A 29ASN A 33ALA A 36GLN A 39MET A 70ARG A 80PHE A 92MET A 108MET A 115CYH A 205THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)None1CA A 247 (-3.9A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.39A | 2ab2B-2q3yA:38.4 | 2ab2B-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 29ASN A 33GLN A 39MET A 70ARG A 80PHE A 92MET A 108MET A 115CYH A 205THR A 208PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)None1CA A 249 (-3.6A)1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.35A | 2ab2B-3ry9A:37.6 | 2ab2B-3ry9A:65.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | LEU A 29PHE A 98MET A 108CYH A 205THR A 208PHE A 219 | 1CA A 249 ( 3.8A)None1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.42A | 2ab2B-3ry9A:37.6 | 2ab2B-3ry9A:65.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_2 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 5 | LEU A 32LEU A 35LEU A 77CYH A 112 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 ( 3.9A)None | 0.21A | 2ab2B-2q3yA:38.4 | 2ab2B-2q3yA:68.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_2 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 5 | LEU A 32LEU A 35LEU A 77CYH A 112 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 ( 4.1A)None | 0.16A | 2ab2B-3ry9A:37.6 | 2ab2B-3ry9A:65.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | ASN A 33LEU A 35TRP A 69MET A 70MET A 73ARG A 80MET A 108LEU A 201 | 1CA A 247 (-2.9A)1CA A 247 ( 4.4A)None1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 4.2A) | 0.47A | 2am9A-2q3yA:37.5 | 2am9A-2q3yA:59.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35GLN A 39TRP A 69MET A 73ARG A 80 | 1CA A 247 ( 4.4A)1CA A 247 (-3.1A)None1CA A 247 (-3.6A)1CA A 247 (-3.8A) | 0.78A | 2am9A-2q3yA:37.5 | 2am9A-2q3yA:59.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 12 | ASN A 33LEU A 35TRP A 69MET A 70MET A 73ARG A 80MET A 108LEU A 201 | 1CA A 249 (-3.0A)1CA A 249 ( 4.4A)None1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A) | 0.69A | 2am9A-3ry9A:37.0 | 2am9A-3ry9A:52.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | LEU A 35GLN A 39TRP A 69MET A 70MET A 73ARG A 80 | 1CA A 249 ( 4.4A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A) | 0.86A | 2am9A-3ry9A:37.0 | 2am9A-3ry9A:52.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ALA A 36TRP A 69LEU A 77ARG A 80MET A 108 | 1CA A 247 (-3.6A)None1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.64A | 2jfaA-2q3yA:25.1 | 2jfaA-2q3yA:26.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_B_RALB600_1 (ESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ALA A 36TRP A 69LEU A 77ARG A 80MET A 108 | 1CA A 247 (-3.6A)None1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.63A | 2jfaB-2q3yA:24.3 | 2jfaB-2q3yA:26.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 28LEU A 35GLN A 39LEU A 77ARG A 80 | None1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 1.17A | 2oaxA-2q3yA:36.8 | 2oaxA-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | LEU A 29ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80MET A 108LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.47A | 2oaxA-2q3yA:36.8 | 2oaxA-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 29ASN A 33LEU A 90CYH A 205THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)None1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.13A | 2oaxA-2q3yA:36.8 | 2oaxA-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 28LEU A 35GLN A 39LEU A 77ARG A 80 | None1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A) | 1.21A | 2oaxA-3ry9A:36.8 | 2oaxA-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 12 / 12 | LEU A 29ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80MET A 108LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.42A | 2oaxA-3ry9A:36.8 | 2oaxA-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | LEU A 29ASN A 33LEU A 90CYH A 205THR A 208PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)None1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.16A | 2oaxA-3ry9A:36.8 | 2oaxA-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 28LEU A 35GLN A 39LEU A 77ARG A 80 | None1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 1.14A | 2oaxB-2q3yA:37.3 | 2oaxB-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | LEU A 29ASN A 33LEU A 35ALA A 36GLN A 39MET A 70LEU A 77ARG A 80LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.34A | 2oaxB-2q3yA:37.3 | 2oaxB-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 29ASN A 33LEU A 90CYH A 205THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)None1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.18A | 2oaxB-2q3yA:37.3 | 2oaxB-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 28LEU A 35GLN A 39LEU A 77ARG A 80 | None1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A) | 1.19A | 2oaxB-3ry9A:37.0 | 2oaxB-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 29ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.33A | 2oaxB-3ry9A:37.0 | 2oaxB-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 29ASN A 33LEU A 90THR A 208PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)None1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.23A | 2oaxB-3ry9A:37.0 | 2oaxB-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_C_SNLC3001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | LEU A 29ASN A 33ALA A 36GLN A 39TRP A 69MET A 70LEU A 77ARG A 80MET A 108LEU A 201THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 4.2A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.43A | 2oaxC-2q3yA:36.4 | 2oaxC-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_C_SNLC3001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 29ASN A 33LEU A 90THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)None1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.14A | 2oaxC-2q3yA:36.4 | 2oaxC-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_C_SNLC3001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 29ASN A 33GLN A 39TRP A 69MET A 70LEU A 77ARG A 80MET A 108LEU A 201THR A 208PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.42A | 2oaxC-3ry9A:36.6 | 2oaxC-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_D_SNLD4001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 28LEU A 35GLN A 39LEU A 77ARG A 80 | None1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 1.23A | 2oaxD-2q3yA:37.4 | 2oaxD-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_D_SNLD4001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | LEU A 29ASN A 33LEU A 35ALA A 36GLN A 39TRP A 69MET A 70LEU A 77ARG A 80MET A 108LEU A 201PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 4.2A)1CA A 247 (-4.5A) | 0.40A | 2oaxD-2q3yA:37.4 | 2oaxD-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_D_SNLD4001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 28LEU A 35GLN A 39LEU A 77ARG A 80 | None1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A) | 1.30A | 2oaxD-3ry9A:37.0 | 2oaxD-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_D_SNLD4001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 29ASN A 33LEU A 35GLN A 39TRP A 69MET A 70LEU A 77ARG A 80MET A 108LEU A 201PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.3A) | 0.34A | 2oaxD-3ry9A:37.0 | 2oaxD-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 28LEU A 35GLN A 39LEU A 77ARG A 80 | None1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 1.19A | 2oaxE-2q3yA:37.0 | 2oaxE-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | LEU A 29ASN A 33LEU A 35ALA A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 108LEU A 201CYH A 205PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-4.5A) | 0.49A | 2oaxE-2q3yA:37.0 | 2oaxE-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 29ASN A 33LEU A 90CYH A 205PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)None1CA A 247 (-4.0A)1CA A 247 (-4.5A) | 1.29A | 2oaxE-2q3yA:37.0 | 2oaxE-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 28LEU A 35GLN A 39LEU A 77ARG A 80 | None1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A) | 1.26A | 2oaxE-3ry9A:36.6 | 2oaxE-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 29ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80MET A 108LEU A 201CYH A 205PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-4.3A) | 0.49A | 2oaxE-3ry9A:36.6 | 2oaxE-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_F_SNLF6001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | ASN A 33LEU A 35ALA A 36GLN A 39TRP A 69MET A 70LEU A 77ARG A 80LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.43A | 2oaxF-2q3yA:37.3 | 2oaxF-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_F_SNLF6001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ASN A 33LEU A 90CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)None1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.12A | 2oaxF-2q3yA:37.3 | 2oaxF-2q3yA:72.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_F_SNLF6001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | ASN A 33LEU A 35GLN A 39TRP A 69MET A 70LEU A 77ARG A 80LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.40A | 2oaxF-3ry9A:35.9 | 2oaxF-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_F_SNLF6001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | ASN A 33LEU A 90CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)None1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.18A | 2oaxF-3ry9A:35.9 | 2oaxF-3ry9A:69.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39ARG A 80MET A 108PHE A 219 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 (-4.5A) | 0.63A | 2oz7A-2q3yA:36.0 | 2oz7A-2q3yA:60.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLY A 36GLN A 39ARG A 80MET A 108PHE A 219 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-4.3A) | 0.60A | 2oz7A-3ry9A:35.5 | 2oz7A-3ry9A:55.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 6 | LEU A 29TRP A 69MET A 70LEU A 201 | 1CA A 247 ( 3.6A)None1CA A 247 ( 3.8A)1CA A 247 ( 4.2A) | 1.29A | 2oz7A-2q3yA:36.0 | 2oz7A-2q3yA:60.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 6 | MET A 70MET A 73MET A 115LEU A 201 | 1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A) | 0.79A | 2oz7A-2q3yA:36.0 | 2oz7A-2q3yA:60.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 6 | TRP A 69MET A 70MET A 115LEU A 201 | None1CA A 247 ( 3.8A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A) | 1.14A | 2oz7A-2q3yA:36.0 | 2oz7A-2q3yA:60.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 6 | LEU A 29MET A 70MET A 73LEU A 201 | 1CA A 249 ( 3.8A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 ( 4.2A) | 1.03A | 2oz7A-3ry9A:35.5 | 2oz7A-3ry9A:55.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 6 | LEU A 29TRP A 69MET A 70LEU A 201 | 1CA A 249 ( 3.8A)None1CA A 249 ( 3.8A)1CA A 249 ( 4.2A) | 1.36A | 2oz7A-3ry9A:35.5 | 2oz7A-3ry9A:55.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 6 | MET A 70MET A 73MET A 115LEU A 201 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A) | 0.69A | 2oz7A-3ry9A:35.5 | 2oz7A-3ry9A:55.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 6 | TRP A 69MET A 70MET A 115LEU A 201 | None1CA A 249 ( 3.8A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A) | 1.26A | 2oz7A-3ry9A:35.5 | 2oz7A-3ry9A:55.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7I_A_TESA205_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80MET A 108 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.39A | 2q7iA-2q3yA:37.5 | 2q7iA-2q3yA:59.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7I_A_TESA205_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80MET A 108 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)1CA A 249 (-3.6A) | 0.48A | 2q7iA-3ry9A:36.9 | 2q7iA-3ry9A:53.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7J_A_TESA203_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | LEU A 29ASN A 33LEU A 35GLN A 39TRP A 69MET A 70MET A 73ARG A 80MET A 108 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.48A | 2q7jA-2q3yA:37.8 | 2q7jA-2q3yA:59.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7J_A_TESA203_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | LEU A 29ASN A 33LEU A 35GLN A 39TRP A 69MET A 70MET A 73ARG A 80MET A 108 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)1CA A 249 (-3.6A) | 0.67A | 2q7jA-3ry9A:36.9 | 2q7jA-3ry9A:53.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7K_A_TESA304_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80MET A 108LEU A 201 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 4.2A) | 0.54A | 2q7kA-2q3yA:37.4 | 2q7kA-2q3yA:59.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7K_A_TESA304_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80MET A 108LEU A 201 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A) | 0.61A | 2q7kA-3ry9A:37.1 | 2q7kA-3ry9A:53.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7L_A_TESA155_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39TRP A 69MET A 70ARG A 80MET A 108 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.39A | 2q7lA-2q3yA:37.8 | 2q7lA-2q3yA:59.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7L_A_TESA155_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | ASN A 33GLY A 37GLN A 39TRP A 69ARG A 80 | 1CA A 249 (-3.0A)None1CA A 249 (-3.0A)None1CA A 249 (-3.5A) | 1.35A | 2q7lA-3ry9A:36.7 | 2q7lA-3ry9A:53.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7L_A_TESA155_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | LEU A 32ASN A 33LEU A 35GLY A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 108 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A) | 0.59A | 2q7lA-3ry9A:36.7 | 2q7lA-3ry9A:53.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | LEU A 29LEU A 35GLN A 39TRP A 69MET A 70MET A 73ARG A 80LEU A 111CYH A 205 | 1CA A 247 ( 3.6A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)None1CA A 247 (-4.0A) | 0.69A | 2w8yA-2q3yA:37.5 | 2w8yA-2q3yA:62.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | GLY A 36TRP A 69MET A 70MET A 73PHE A 98 | 1CA A 249 ( 4.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.9A)None | 1.25A | 2w8yA-3ry9A:36.6 | 2w8yA-3ry9A:61.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 28LEU A 35GLY A 36GLN A 39ARG A 80 | None1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 (-3.5A) | 1.38A | 2w8yA-3ry9A:36.6 | 2w8yA-3ry9A:61.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | LEU A 29GLY A 36GLN A 39MET A 70ARG A 80LEU A 111CYH A 205 | 1CA A 249 ( 3.8A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)None1CA A 249 (-4.0A) | 0.76A | 2w8yA-3ry9A:36.6 | 2w8yA-3ry9A:61.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | LEU A 29GLY A 37GLN A 39TRP A 69MET A 70CYH A 205 | 1CA A 249 ( 3.8A)None1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-4.0A) | 1.23A | 2w8yA-3ry9A:36.6 | 2w8yA-3ry9A:61.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | LEU A 29LEU A 35GLY A 36GLN A 39TRP A 69MET A 70MET A 73ARG A 80CYH A 205 | 1CA A 249 ( 3.8A)1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)1CA A 249 (-4.0A) | 0.57A | 2w8yA-3ry9A:36.6 | 2w8yA-3ry9A:61.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 29ASN A 33MET A 70LEU A 111CYH A 205 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 ( 3.8A)None1CA A 247 (-4.0A) | 0.87A | 2w8yB-2q3yA:37.7 | 2w8yB-2q3yA:62.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 10 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80MET A 115CYH A 205 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A) | 0.42A | 2w8yB-2q3yA:37.7 | 2w8yB-2q3yA:62.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35LEU A 32LEU A 29LEU A 77MET A 115 | 1CA A 247 ( 4.4A)1CA A 247 (-4.0A)1CA A 247 ( 3.6A)1CA A 247 ( 3.9A)1CA A 247 ( 3.7A) | 1.19A | 2w8yB-2q3yA:37.7 | 2w8yB-2q3yA:62.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80MET A 115CYH A 205 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-4.0A) | 0.50A | 2w8yB-3ry9A:36.7 | 2w8yB-3ry9A:61.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 29MET A 70ARG A 80LEU A 111CYH A 205 | 1CA A 249 ( 3.8A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)None1CA A 249 (-4.0A) | 0.95A | 2w8yB-3ry9A:36.7 | 2w8yB-3ry9A:61.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 35LEU A 32LEU A 29LEU A 77MET A 115 | 1CA A 249 ( 4.4A)1CA A 249 (-3.9A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.6A) | 1.24A | 2w8yB-3ry9A:36.7 | 2w8yB-3ry9A:61.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YHD_A_TESA1920_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | LEU A 29ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80MET A 108 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.47A | 2yhdA-2q3yA:37.3 | 2yhdA-2q3yA:60.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YHD_A_TESA1920_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | LEU A 29ASN A 33LEU A 35GLY A 36GLN A 39MET A 70MET A 73ARG A 80MET A 108 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)1CA A 249 (-3.6A) | 0.54A | 2yhdA-3ry9A:36.6 | 2yhdA-3ry9A:55.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLO_A_TESA1920_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | LEU A 32ASN A 33LEU A 35MET A 70MET A 73ARG A 80PHE A 219 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)1CA A 247 (-4.5A) | 0.50A | 2yloA-2q3yA:37.3 | 2yloA-2q3yA:58.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLO_A_TESA1920_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | LEU A 32LEU A 35GLN A 39MET A 70MET A 73ARG A 80PHE A 219 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)1CA A 247 (-4.5A) | 0.69A | 2yloA-2q3yA:37.3 | 2yloA-2q3yA:58.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLO_A_TESA1920_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | LEU A 32ASN A 33LEU A 35MET A 70MET A 73ARG A 80PHE A 219 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)1CA A 249 (-4.3A) | 0.55A | 2yloA-3ry9A:36.8 | 2yloA-3ry9A:53.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLO_A_TESA1920_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | LEU A 32LEU A 35GLN A 39MET A 70MET A 73ARG A 80PHE A 219 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)1CA A 249 (-4.3A) | 0.72A | 2yloA-3ry9A:36.8 | 2yloA-3ry9A:53.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLP_A_TESA1921_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 11 | LEU A 29ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80LEU A 201 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)1CA A 247 ( 4.2A) | 0.54A | 2ylpA-2q3yA:37.5 | 2ylpA-2q3yA:58.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLP_A_TESA1921_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 11 | LEU A 29ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80LEU A 201 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)1CA A 249 ( 4.2A) | 0.64A | 2ylpA-3ry9A:36.9 | 2ylpA-3ry9A:53.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLQ_A_TESA1921_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 11 | LEU A 29ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A) | 0.46A | 2ylqA-2q3yA:37.6 | 2ylqA-2q3yA:58.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLQ_A_TESA1921_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 11 | LEU A 29ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A) | 0.56A | 2ylqA-3ry9A:37.0 | 2ylqA-3ry9A:53.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 10 / 12 | ASN A 33GLN A 39MET A 70LEU A 77ARG A 80CYH A 112LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)None1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.48A | 3cldA-2q3yA:35.8 | 3cldA-2q3yA:62.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)None1CA A 247 ( 3.8A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.07A | 3cldA-2q3yA:35.8 | 3cldA-2q3yA:62.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | ASN A 33GLY A 36GLN A 39MET A 70LEU A 77ARG A 80CYH A 112LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)None1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.46A | 3cldA-3ry9A:36.0 | 3cldA-3ry9A:71.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.00A | 3cldA-3ry9A:36.0 | 3cldA-3ry9A:71.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_2 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 9 | LEU A 32LEU A 35TRP A 69MET A 73ALA A 74MET A 115 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)None1CA A 247 (-3.6A)1CA A 247 ( 4.4A)1CA A 247 ( 3.7A) | 0.79A | 3cldA-2q3yA:35.8 | 3cldA-2q3yA:62.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_2 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 9 | LEU A 32LEU A 35TRP A 69MET A 73ALA A 74 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)None1CA A 249 (-3.9A)1CA A 249 ( 4.7A) | 0.59A | 3cldA-3ry9A:36.0 | 3cldA-3ry9A:71.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_2 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 9 | LEU A 32LEU A 35TRP A 69MET A 73MET A 115 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)None1CA A 249 (-3.9A)1CA A 249 (-3.6A) | 0.73A | 3cldA-3ry9A:36.0 | 3cldA-3ry9A:71.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | ASN A 33GLN A 39MET A 70ARG A 80CYH A 112LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)None1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.49A | 3cldB-2q3yA:35.9 | 3cldB-2q3yA:62.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ASN A 33GLY A 37CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)None1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.82A | 3cldB-2q3yA:35.9 | 3cldB-2q3yA:62.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | ASN A 33GLY A 36GLN A 39MET A 70ARG A 80CYH A 112LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)None1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.48A | 3cldB-3ry9A:35.9 | 3cldB-3ry9A:71.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.99A | 3cldB-3ry9A:35.9 | 3cldB-3ry9A:71.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_2 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 8 | LEU A 32MET A 73ALA A 74LEU A 77 | 1CA A 247 (-4.0A)1CA A 247 (-3.6A)1CA A 247 ( 4.4A)1CA A 247 ( 3.9A) | 0.62A | 3cldB-2q3yA:35.9 | 3cldB-2q3yA:62.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_2 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 8 | LEU A 32MET A 73LEU A 77MET A 115 | 1CA A 247 (-4.0A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 ( 3.7A) | 0.72A | 3cldB-2q3yA:35.9 | 3cldB-2q3yA:62.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_2 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 8 | LEU A 32MET A 73ALA A 74LEU A 77 | 1CA A 249 (-3.9A)1CA A 249 (-3.9A)1CA A 249 ( 4.7A)1CA A 249 ( 4.1A) | 0.50A | 3cldB-3ry9A:35.9 | 3cldB-3ry9A:71.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_2 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 8 | LEU A 32MET A 73LEU A 77MET A 115 | 1CA A 249 (-3.9A)1CA A 249 (-3.9A)1CA A 249 ( 4.1A)1CA A 249 (-3.6A) | 0.64A | 3cldB-3ry9A:35.9 | 3cldB-3ry9A:71.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | LEU A 29ASN A 33GLN A 39MET A 70ARG A 80LEU A 111CYH A 205 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)None1CA A 247 (-4.0A) | 0.70A | 3d90A-2q3yA:36.7 | 3d90A-2q3yA:63.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 10 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80MET A 115CYH A 205 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A) | 0.48A | 3d90A-2q3yA:36.7 | 3d90A-2q3yA:63.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35LEU A 32LEU A 29LEU A 77MET A 115 | 1CA A 247 ( 4.4A)1CA A 247 (-4.0A)1CA A 247 ( 3.6A)1CA A 247 ( 3.9A)1CA A 247 ( 3.7A) | 1.19A | 3d90A-2q3yA:36.7 | 3d90A-2q3yA:63.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | LEU A 29ASN A 33MET A 70ARG A 80LEU A 111CYH A 205 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)None1CA A 249 (-4.0A) | 0.80A | 3d90A-3ry9A:35.8 | 3d90A-3ry9A:62.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80MET A 115CYH A 205 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-4.0A) | 0.56A | 3d90A-3ry9A:35.8 | 3d90A-3ry9A:62.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 35LEU A 32LEU A 29LEU A 77MET A 115 | 1CA A 249 ( 4.4A)1CA A 249 (-3.9A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.6A) | 1.25A | 3d90A-3ry9A:35.8 | 3d90A-3ry9A:62.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 11 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80LEU A 111MET A 115CYH A 205 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A)1CA A 247 (-4.0A) | 0.66A | 3d90B-2q3yA:36.8 | 3d90B-2q3yA:63.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35LEU A 32LEU A 29LEU A 77MET A 115 | 1CA A 247 ( 4.4A)1CA A 247 (-4.0A)1CA A 247 ( 3.6A)1CA A 247 ( 3.9A)1CA A 247 ( 3.7A) | 1.28A | 3d90B-2q3yA:36.8 | 3d90B-2q3yA:63.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80LEU A 111MET A 115CYH A 205 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)None1CA A 249 (-3.6A)1CA A 249 (-4.0A) | 0.74A | 3d90B-3ry9A:36.3 | 3d90B-3ry9A:62.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 32LEU A 96LEU A 90LEU A 201MET A 115 | 1CA A 249 (-3.9A)NoneNone1CA A 249 ( 4.2A)1CA A 249 (-3.6A) | 1.30A | 3d90B-3ry9A:36.3 | 3d90B-3ry9A:62.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ERD_A_DESA600_1 (ESTROGEN RECEPTORALPHA) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 32ALA A 36LEU A 77ARG A 80MET A 108 | 1CA A 247 (-4.0A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.50A | 3erdA-2q3yA:28.1 | 3erdA-2q3yA:26.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | ASN A 33GLY A 37TRP A 69CYH A 205THR A 208VAL A 217 | 1CA A 247 (-2.9A)NoneNone1CA A 247 (-4.0A)1CA A 247 (-3.4A)None | 0.98A | 3gn8A-2q3yA:37.0 | 3gn8A-2q3yA:76.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | LEU A 32ASN A 33GLN A 39TRP A 69MET A 70ARG A 80CYH A 205THR A 208VAL A 217 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)None | 0.47A | 3gn8A-2q3yA:37.0 | 3gn8A-2q3yA:76.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | LEU A 32ASN A 33GLN A 39TRP A 69MET A 70ARG A 80MET A 115CYH A 205THR A 208 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.75A | 3gn8A-2q3yA:37.0 | 3gn8A-2q3yA:76.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | ASN A 33GLY A 37TRP A 69CYH A 205THR A 208VAL A 217 | 1CA A 249 (-3.0A)NoneNone1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.9A) | 0.92A | 3gn8A-3ry9A:36.4 | 3gn8A-3ry9A:84.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80CYH A 205THR A 208VAL A 217 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.9A) | 0.43A | 3gn8A-3ry9A:36.4 | 3gn8A-3ry9A:84.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 115CYH A 205THR A 208 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A) | 0.78A | 3gn8A-3ry9A:36.4 | 3gn8A-3ry9A:84.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | ASN A 33GLY A 37TRP A 69CYH A 205THR A 208VAL A 217PHE A 219 | 1CA A 247 (-2.9A)NoneNone1CA A 247 (-4.0A)1CA A 247 (-3.4A)None1CA A 247 (-4.5A) | 0.94A | 3gn8B-2q3yA:36.9 | 3gn8B-2q3yA:76.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 10 / 12 | LEU A 32ASN A 33GLN A 39TRP A 69MET A 70ARG A 80CYH A 205THR A 208VAL A 217PHE A 219 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)None1CA A 247 (-4.5A) | 0.46A | 3gn8B-2q3yA:36.9 | 3gn8B-2q3yA:76.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | LEU A 32ASN A 33GLN A 39TRP A 69MET A 70ARG A 80MET A 115CYH A 205PHE A 219 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 (-4.0A)1CA A 247 (-4.5A) | 0.73A | 3gn8B-2q3yA:36.9 | 3gn8B-2q3yA:76.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 12 | ASN A 33GLY A 37TRP A 69MET A 70CYH A 205THR A 208VAL A 217PHE A 219 | 1CA A 249 (-3.0A)NoneNone1CA A 249 ( 3.8A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.9A)1CA A 249 (-4.3A) | 0.88A | 3gn8B-3ry9A:36.2 | 3gn8B-3ry9A:84.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80CYH A 205THR A 208VAL A 217PHE A 219 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.9A)1CA A 249 (-4.3A) | 0.42A | 3gn8B-3ry9A:36.2 | 3gn8B-3ry9A:84.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 115CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.75A | 3gn8B-3ry9A:36.2 | 3gn8B-3ry9A:84.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | LEU A 32ASN A 33GLN A 39MET A 70ARG A 80MET A 115LEU A 201 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A) | 0.78A | 3h52A-2q3yA:25.8 | 3h52A-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39MET A 70ARG A 80MET A 115LEU A 201 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A) | 0.80A | 3h52A-3ry9A:26.2 | 3h52A-3ry9A:70.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 10 | LEU A 32TRP A 69MET A 70MET A 73LEU A 201 | 1CA A 247 (-4.0A)None1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 ( 4.2A) | 0.49A | 3h52B-2q3yA:28.1 | 3h52B-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 10 | LEU A 32TRP A 69MET A 70MET A 73LEU A 223 | 1CA A 247 (-4.0A)None1CA A 247 ( 3.8A)1CA A 247 (-3.6A)None | 1.32A | 3h52B-2q3yA:28.1 | 3h52B-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 10 | LEU A 35TRP A 69MET A 70MET A 222LEU A 223 | 1CA A 247 ( 4.4A)None1CA A 247 ( 3.8A)NoneNone | 1.12A | 3h52B-2q3yA:28.1 | 3h52B-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 10 | TRP A 69MET A 70MET A 73MET A 222LEU A 223 | None1CA A 247 ( 3.8A)1CA A 247 (-3.6A)NoneNone | 1.21A | 3h52B-2q3yA:28.1 | 3h52B-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 10 | LEU A 32TRP A 69MET A 70MET A 73LEU A 201 | 1CA A 249 (-3.9A)None1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 ( 4.2A) | 0.70A | 3h52B-3ry9A:27.8 | 3h52B-3ry9A:70.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 10 | LEU A 35TRP A 69MET A 70MET A 222LEU A 223 | 1CA A 249 ( 4.4A)None1CA A 249 ( 3.8A)NoneNone | 1.29A | 3h52B-3ry9A:27.8 | 3h52B-3ry9A:70.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | GLN A 39LEU A 77ARG A 80CYH A 112MET A 115ILE A 227 | 1CA A 247 (-3.1A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A)None | 1.17A | 3h52B-2q3yA:28.1 | 3h52B-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | GLN A 39VAL A 43LEU A 77ARG A 80ILE A 65 | 1CA A 247 (-3.1A)None1CA A 247 ( 3.9A)1CA A 247 (-3.8A)None | 1.26A | 3h52B-2q3yA:28.1 | 3h52B-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | GLY A 37GLN A 39ARG A 80CYH A 205ILE A 226 | None1CA A 247 (-3.1A)1CA A 247 (-3.8A)1CA A 247 (-4.0A)None | 0.83A | 3h52B-2q3yA:28.1 | 3h52B-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | GLY A 37GLN A 39LEU A 77ARG A 80CYH A 112MET A 115CYH A 205 | None1CA A 247 (-3.1A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A)1CA A 247 (-4.0A) | 0.88A | 3h52B-2q3yA:28.1 | 3h52B-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | GLY A 37GLN A 39LEU A 77ARG A 80MET A 108CYH A 112MET A 115 | None1CA A 247 (-3.1A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)None1CA A 247 ( 3.7A) | 1.40A | 3h52B-2q3yA:28.1 | 3h52B-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | GLN A 39LEU A 77ARG A 80MET A 108CYH A 112MET A 115 | 1CA A 249 (-3.0A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)None1CA A 249 (-3.6A) | 1.28A | 3h52B-3ry9A:27.8 | 3h52B-3ry9A:70.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | GLY A 36GLN A 39LEU A 77ARG A 80MET A 115ILE A 227 | 1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)None | 1.39A | 3h52B-3ry9A:27.8 | 3h52B-3ry9A:70.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | GLY A 36GLY A 37GLN A 39LEU A 77ARG A 80CYH A 112MET A 115CYH A 205ILE A 226 | 1CA A 249 ( 4.0A)None1CA A 249 (-3.0A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)None1CA A 249 (-3.6A)1CA A 249 (-4.0A)None | 0.85A | 3h52B-3ry9A:27.8 | 3h52B-3ry9A:70.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | GLN A 39TRP A 69MET A 70LEU A 77ARG A 80PHE A 92MET A 115 | 1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A) | 0.62A | 3h52C-2q3yA:26.6 | 3h52C-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 32GLN A 39TRP A 69ARG A 80PHE A 92MET A 115 | 1CA A 247 (-4.0A)1CA A 247 (-3.1A)None1CA A 247 (-3.8A)None1CA A 247 ( 3.7A) | 0.91A | 3h52C-2q3yA:26.6 | 3h52C-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 12 | GLY A 36GLN A 39TRP A 69MET A 70LEU A 77ARG A 80PHE A 92MET A 115 | 1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)None1CA A 249 (-3.6A) | 0.74A | 3h52C-3ry9A:25.6 | 3h52C-3ry9A:70.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | LEU A 32GLY A 36GLN A 39TRP A 69ARG A 80PHE A 92MET A 115 | 1CA A 249 (-3.9A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 (-3.5A)None1CA A 249 (-3.6A) | 0.97A | 3h52C-3ry9A:25.6 | 3h52C-3ry9A:70.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | GLN A 39LEU A 77ARG A 80MET A 108MET A 115 | 1CA A 247 (-3.1A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 3.7A) | 0.99A | 3h52D-2q3yA:28.0 | 3h52D-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | GLN A 39MET A 70ARG A 80LEU A 201CYH A 205 | 1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A) | 0.89A | 3h52D-2q3yA:28.0 | 3h52D-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | GLN A 39MET A 70LEU A 77ARG A 80MET A 115LEU A 201 | 1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A) | 0.74A | 3h52D-2q3yA:28.0 | 3h52D-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 77ARG A 80MET A 108MET A 115LEU A 197 | 1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 3.7A)None | 0.93A | 3h52D-2q3yA:28.0 | 3h52D-2q3yA:63.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | GLY A 36GLN A 39LEU A 77ARG A 80MET A 108MET A 115 | 1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-3.6A) | 1.05A | 3h52D-3ry9A:27.0 | 3h52D-3ry9A:70.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | GLY A 36GLN A 39MET A 70ARG A 80MET A 115LEU A 201CYH A 205 | 1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A) | 1.04A | 3h52D-3ry9A:27.0 | 3h52D-3ry9A:70.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | GLY A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 115LEU A 201 | 1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A) | 0.82A | 3h52D-3ry9A:27.0 | 3h52D-3ry9A:70.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 77ARG A 80MET A 108MET A 115LEU A 197 | 1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-3.6A)None | 1.02A | 3h52D-3ry9A:27.0 | 3h52D-3ry9A:70.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HM1_A_J3ZA2_1 (ESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 32ALA A 36LEU A 77ARG A 80MET A 108 | 1CA A 247 (-4.0A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.44A | 3hm1A-2q3yA:29.0 | 3hm1A-2q3yA:27.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HM1_B_J3ZB1_1 (ESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 11 | LEU A 32LEU A 35LEU A 77ARG A 80MET A 108 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.37A | 3hm1B-2q3yA:28.5 | 3hm1B-2q3yA:27.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HM1_B_J3ZB1_1 (ESTROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 11 | LEU A 32LEU A 35LEU A 77ARG A 80MET A 108 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A) | 0.34A | 3hm1B-3ry9A:28.1 | 3hm1B-3ry9A:29.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | ASN A 33GLN A 39TRP A 69MET A 70ARG A 80LEU A 201THR A 208PHE A 219 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 4.2A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.47A | 3mneA-2q3yA:35.6 | 3mneA-2q3yA:62.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | ASN A 33GLN A 39TRP A 69MET A 70ARG A 80MET A 115LEU A 201THR A 208 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A)1CA A 247 (-3.4A) | 0.75A | 3mneA-2q3yA:35.6 | 3mneA-2q3yA:62.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | ASN A 33GLY A 37TRP A 69MET A 70THR A 208PHE A 219 | 1CA A 247 (-2.9A)NoneNone1CA A 247 ( 3.8A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.01A | 3mneA-2q3yA:35.6 | 3mneA-2q3yA:62.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80LEU A 201THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 ( 4.2A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.45A | 3mneA-3ry9A:35.2 | 3mneA-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 115LEU A 201THR A 208 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-3.2A) | 0.79A | 3mneA-3ry9A:35.2 | 3mneA-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | ASN A 33GLY A 37TRP A 69MET A 70THR A 208PHE A 219 | 1CA A 249 (-3.0A)NoneNone1CA A 249 ( 3.8A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.92A | 3mneA-3ry9A:35.2 | 3mneA-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | ASN A 33GLN A 39MET A 70ARG A 80LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.49A | 3mnoA-2q3yA:36.3 | 3mnoA-2q3yA:62.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)None1CA A 247 ( 3.8A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.96A | 3mnoA-2q3yA:36.3 | 3mnoA-2q3yA:62.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | GLN A 39MET A 70ARG A 80MET A 115LEU A 201 | 1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A) | 0.96A | 3mnoA-2q3yA:36.3 | 3mnoA-2q3yA:62.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | ASN A 33GLY A 36GLN A 39MET A 70ARG A 80LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.45A | 3mnoA-3ry9A:34.8 | 3mnoA-3ry9A:71.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.89A | 3mnoA-3ry9A:34.8 | 3mnoA-3ry9A:71.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | GLY A 36GLN A 39MET A 70ARG A 80MET A 115LEU A 201 | 1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A) | 0.95A | 3mnoA-3ry9A:34.8 | 3mnoA-3ry9A:71.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | ASN A 33GLN A 39MET A 70ARG A 80LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.52A | 3mnpA-2q3yA:36.9 | 3mnpA-2q3yA:61.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 219 | 1CA A 247 (-2.9A)None1CA A 247 ( 3.8A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.97A | 3mnpA-2q3yA:36.9 | 3mnpA-2q3yA:61.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | GLN A 39MET A 70ARG A 80MET A 115LEU A 201 | 1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A) | 1.00A | 3mnpA-2q3yA:36.9 | 3mnpA-2q3yA:61.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | ASN A 33GLY A 36GLN A 39MET A 70ARG A 80LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.46A | 3mnpA-3ry9A:35.5 | 3mnpA-3ry9A:69.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.90A | 3mnpA-3ry9A:35.5 | 3mnpA-3ry9A:69.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | GLY A 36GLN A 39MET A 70ARG A 80MET A 115LEU A 201 | 1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A) | 1.00A | 3mnpA-3ry9A:35.5 | 3mnpA-3ry9A:69.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLL_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 10 | LEU A 32LEU A 35MET A 70LEU A 77ARG A 80 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 0.33A | 3ollA-2q3yA:28.0 | 3ollA-2q3yA:29.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLL_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 10 | LEU A 32LEU A 35MET A 70LEU A 77ARG A 80 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A) | 0.30A | 3ollA-3ry9A:27.6 | 3ollA-3ry9A:29.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLS_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 32LEU A 35ALA A 36MET A 70LEU A 77ARG A 80 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 0.35A | 3olsA-2q3yA:29.2 | 3olsA-2q3yA:29.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLS_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 32LEU A 35MET A 70LEU A 77ARG A 80 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A) | 0.27A | 3olsA-3ry9A:28.6 | 3olsA-3ry9A:29.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLS_B_ESTB600_1 (ESTROGEN RECEPTORBETA) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 32ALA A 36MET A 70LEU A 77ARG A 80 | 1CA A 247 (-4.0A)1CA A 247 (-3.6A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 0.34A | 3olsB-2q3yA:28.3 | 3olsB-2q3yA:29.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VHU_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | LEU A 29ASN A 33ALA A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 108LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.31A | 3vhuA-2q3yA:39.0 | 3vhuA-2q3yA:64.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VHU_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 29ASN A 33LEU A 90CYH A 205THR A 208PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)None1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.19A | 3vhuA-2q3yA:39.0 | 3vhuA-2q3yA:64.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VHU_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 29ASN A 33GLN A 39MET A 70LEU A 77ARG A 80MET A 108LEU A 201CYH A 205THR A 208PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.30A | 3vhuA-3ry9A:37.7 | 3vhuA-3ry9A:65.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VHU_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 29ASN A 33LEU A 90THR A 208PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)None1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.23A | 3vhuA-3ry9A:37.7 | 3vhuA-3ry9A:65.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZQT_A_TESA1000_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A) | 0.70A | 3zqtA-2q3yA:37.4 | 3zqtA-2q3yA:58.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZQT_A_TESA1000_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35MET A 70MET A 73ARG A 80 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A) | 0.58A | 3zqtA-3ry9A:36.8 | 3zqtA-3ry9A:53.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZQT_A_TESA1000_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | LEU A 29LEU A 32LEU A 35GLN A 39MET A 70MET A 73ARG A 80 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A) | 0.70A | 3zqtA-3ry9A:36.8 | 3zqtA-3ry9A:53.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_A_STRA301_1 (STEROID RECEPTOR 2) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 12 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35ALA A 36GLN A 39MET A 70ALA A 74ARG A 80MET A 108CYH A 205THR A 208 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 4.4A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 (-4.0A)1CA A 247 (-3.4A) | 0.33A | 4fn9A-2q3yA:40.1 | 4fn9A-2q3yA:90.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_A_STRA301_1 (STEROID RECEPTOR 2) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ALA A 74ARG A 80MET A 108CYH A 205THR A 208 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.7A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-4.0A)1CA A 249 (-3.2A) | 0.38A | 4fn9A-3ry9A:38.0 | 4fn9A-3ry9A:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_B_STRB301_1 (STEROID RECEPTOR 2) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 11 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35ALA A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 108THR A 208 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 (-3.4A) | 0.38A | 4fn9B-2q3yA:40.0 | 4fn9B-2q3yA:90.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_B_STRB301_1 (STEROID RECEPTOR 2) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39TRP A 69MET A 70ARG A 80MET A 108THR A 208 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-3.2A) | 0.46A | 4fn9B-3ry9A:37.6 | 4fn9B-3ry9A:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HLW_A_TESA1001_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | LEU A 32ASN A 33GLN A 39TRP A 69MET A 70MET A 73ARG A 80 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A) | 0.42A | 4hlwA-2q3yA:37.4 | 4hlwA-2q3yA:58.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HLW_A_TESA1001_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | ASN A 33GLY A 37GLN A 39TRP A 69ARG A 80 | 1CA A 249 (-3.0A)None1CA A 249 (-3.0A)None1CA A 249 (-3.5A) | 1.38A | 4hlwA-3ry9A:36.7 | 4hlwA-3ry9A:53.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HLW_A_TESA1001_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39TRP A 69MET A 70MET A 73ARG A 80 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A) | 0.61A | 4hlwA-3ry9A:36.7 | 4hlwA-3ry9A:53.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4J24_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 32LEU A 35MET A 70LEU A 77ARG A 80 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 0.26A | 4j24A-2q3yA:29.1 | 4j24A-2q3yA:29.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4J24_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 32LEU A 35MET A 70LEU A 77ARG A 80 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A) | 0.30A | 4j24A-3ry9A:28.5 | 4j24A-3ry9A:29.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4J24_D_ESTD600_1 (ESTROGEN RECEPTORBETA) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35ALA A 36MET A 70LEU A 77ARG A 80 | 1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 0.26A | 4j24D-2q3yA:28.7 | 4j24D-2q3yA:29.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 9 | THR A 25LEU A 29ALA A 107LEU A 111GLN A 203PHE A 204TYR A 207THR A 208LEU A 215 | None1CA A 247 ( 3.6A)GOL A 248 (-4.5A)NoneNone1CA A 247 (-4.7A)None1CA A 247 (-3.4A)None | 0.49A | 4ltwA-2q3yA:40.6 | 4ltwA-2q3yA:90.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 9 | THR A 25LEU A 29LEU A 111GLN A 203PHE A 204TYR A 207THR A 208LEU A 215 | None1CA A 249 ( 3.8A)NoneNone1CA A 249 (-4.8A)None1CA A 249 (-3.2A)None | 0.49A | 4ltwA-3ry9A:38.4 | 4ltwA-3ry9A:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_1 (ANCESTRAL STEROIDRECEPTOR 2) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 11 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35ALA A 36GLN A 39MET A 70ARG A 80MET A 108LEU A 201CYH A 205 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A) | 0.23A | 4ltwA-2q3yA:40.6 | 4ltwA-2q3yA:90.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_1 (ANCESTRAL STEROIDRECEPTOR 2) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 29LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80MET A 108LEU A 201CYH A 205 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A) | 0.28A | 4ltwA-3ry9A:38.4 | 4ltwA-3ry9A:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_2 (ANCESTRAL STEROIDRECEPTOR 2) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 8 | TRP A 69MET A 73ALA A 74MET A 115PHE A 204THR A 208VAL A 217PHE A 219 | None1CA A 247 (-3.6A)1CA A 247 ( 4.4A)1CA A 247 ( 3.7A)1CA A 247 (-4.7A)1CA A 247 (-3.4A)None1CA A 247 (-4.5A) | 0.34A | 4ltwA-2q3yA:40.6 | 4ltwA-2q3yA:90.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_2 (ANCESTRAL STEROIDRECEPTOR 2) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 8 | TRP A 69MET A 73ALA A 74MET A 115PHE A 204THR A 208VAL A 217PHE A 219 | None1CA A 249 (-3.9A)1CA A 249 ( 4.7A)1CA A 249 (-3.6A)1CA A 249 (-4.8A)1CA A 249 (-3.2A)1CA A 249 (-4.9A)1CA A 249 (-4.3A) | 0.51A | 4ltwA-3ry9A:38.4 | 4ltwA-3ry9A:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OJB_A_198A1001_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35GLN A 39MET A 70MET A 73ARG A 80 | 1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A) | 0.33A | 4ojbA-2q3yA:36.9 | 4ojbA-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OJB_A_198A1001_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | LEU A 35GLY A 36GLN A 39MET A 70MET A 73ARG A 80 | 1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A) | 0.55A | 4ojbA-3ry9A:36.5 | 4ojbA-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OJB_A_198A1001_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 7 | ASN A 33LEU A 201ILE A 226ILE A 227 | 1CA A 249 (-3.0A)1CA A 249 ( 4.2A)NoneNone | 0.45A | 4ojbA-3ry9A:36.5 | 4ojbA-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OJB_A_198A1001_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 7 | LEU A 32ASN A 33ILE A 226ILE A 227 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)NoneNone | 0.51A | 4ojbA-3ry9A:36.5 | 4ojbA-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OK1_A_198A1001_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 32LEU A 35GLN A 39MET A 70ARG A 80ILE A 227 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)None | 0.61A | 4ok1A-2q3yA:37.1 | 4ok1A-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OK1_A_198A1001_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | LEU A 32LEU A 35GLY A 36GLN A 39MET A 70ARG A 80ILE A 227 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)None | 0.61A | 4ok1A-3ry9A:36.1 | 4ok1A-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OK1_A_198A1001_2 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 8 | ASN A 33MET A 73MET A 115LEU A 201ILE A 226 | 1CA A 247 (-2.9A)1CA A 247 (-3.6A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A)None | 0.87A | 4ok1A-2q3yA:37.1 | 4ok1A-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OK1_A_198A1001_2 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 8 | LEU A 29ASN A 33MET A 73MET A 115LEU A 201 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 (-3.6A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A) | 0.86A | 4ok1A-2q3yA:37.1 | 4ok1A-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OK1_A_198A1001_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 8 | ASN A 33MET A 73LEU A 201ILE A 226 | 1CA A 249 (-3.0A)1CA A 249 (-3.9A)1CA A 249 ( 4.2A)None | 0.84A | 4ok1A-3ry9A:36.1 | 4ok1A-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKB_A_198A1002_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 35GLN A 39MET A 70MET A 73ARG A 80ILE A 227 | 1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)None | 0.57A | 4okbA-2q3yA:36.8 | 4okbA-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKB_A_198A1002_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | LEU A 35GLY A 36GLN A 39MET A 70MET A 73ARG A 80ILE A 227 | 1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)None | 0.70A | 4okbA-3ry9A:36.3 | 4okbA-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKB_A_198A1002_2 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 6 | LEU A 32ASN A 33MET A 115LEU A 201 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A) | 0.90A | 4okbA-2q3yA:36.8 | 4okbA-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKB_A_198A1002_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 6 | LEU A 32ASN A 33MET A 115LEU A 201 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A) | 0.95A | 4okbA-3ry9A:36.3 | 4okbA-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKB_A_198A1002_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 6 | LEU A 77MET A 108LEU A 32MET A 40 | 1CA A 249 ( 4.1A)1CA A 249 (-3.6A)1CA A 249 (-3.9A)None | 1.19A | 4okbA-3ry9A:36.3 | 4okbA-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKT_A_198A1001_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | LEU A 32LEU A 35GLN A 39MET A 70ARG A 80MET A 115ILE A 227 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)None | 0.64A | 4oktA-2q3yA:36.8 | 4oktA-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKT_A_198A1001_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 12 | LEU A 32LEU A 35GLY A 36GLN A 39MET A 70ARG A 80MET A 115ILE A 227 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)None | 0.67A | 4oktA-3ry9A:35.8 | 4oktA-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKW_A_198A1001_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 35GLN A 39MET A 70MET A 73ARG A 80ILE A 227 | 1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)None | 0.47A | 4okwA-2q3yA:37.0 | 4okwA-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKW_A_198A1001_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | LEU A 35GLY A 36GLN A 39MET A 70MET A 73ARG A 80ILE A 227 | 1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)None | 0.58A | 4okwA-3ry9A:36.4 | 4okwA-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKX_A_198A1002_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35GLN A 39MET A 70MET A 73ARG A 80 | 1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A) | 0.33A | 4okxA-2q3yA:37.1 | 4okxA-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKX_A_198A1002_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | LEU A 35GLY A 36GLN A 39MET A 70MET A 73ARG A 80 | 1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A) | 0.54A | 4okxA-3ry9A:36.5 | 4okxA-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKX_A_198A1002_2 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 6 | LEU A 32ASN A 33LEU A 201ILE A 227 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.2A)None | 0.74A | 4okxA-2q3yA:37.1 | 4okxA-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKX_A_198A1002_2 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 6 | LEU A 32MET A 115LEU A 201ILE A 227 | 1CA A 247 (-4.0A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A)None | 0.92A | 4okxA-2q3yA:37.1 | 4okxA-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKX_A_198A1002_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 6 | LEU A 32ASN A 33LEU A 201ILE A 227 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.2A)None | 0.64A | 4okxA-3ry9A:36.5 | 4okxA-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKX_A_198A1002_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 6 | LEU A 32MET A 115LEU A 201ILE A 227 | 1CA A 249 (-3.9A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)None | 0.93A | 4okxA-3ry9A:36.5 | 4okxA-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OLM_A_198A1001_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 32LEU A 35GLN A 39MET A 70MET A 73ARG A 80 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A) | 0.47A | 4olmA-2q3yA:36.4 | 4olmA-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OLM_A_198A1001_1 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35GLN A 39MET A 73ARG A 80MET A 222 | 1CA A 247 ( 4.4A)1CA A 247 (-3.1A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)None | 1.15A | 4olmA-2q3yA:36.4 | 4olmA-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OLM_A_198A1001_1 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 7 / 12 | LEU A 32LEU A 35GLY A 36GLN A 39MET A 70MET A 73ARG A 80 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A) | 0.56A | 4olmA-3ry9A:35.7 | 4olmA-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OLM_A_198A1001_2 (ANDROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 6 | ASN A 33MET A 115ILE A 226ILE A 227 | 1CA A 247 (-2.9A)1CA A 247 ( 3.7A)NoneNone | 0.79A | 4olmA-2q3yA:36.4 | 4olmA-2q3yA:59.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OLM_A_198A1001_2 (ANDROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 6 | ASN A 33MET A 115ILE A 226ILE A 227 | 1CA A 249 (-3.0A)1CA A 249 (-3.6A)NoneNone | 0.78A | 4olmA-3ry9A:35.7 | 4olmA-3ry9A:54.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | LEU A 32ASN A 33GLN A 39MET A 70LEU A 77ARG A 80THR A 208PHE A 219 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.63A | 4p6xA-2q3yA:35.9 | 4p6xA-2q3yA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39MET A 70LEU A 77ARG A 80THR A 208PHE A 219 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.56A | 4p6xA-3ry9A:36.1 | 4p6xA-3ry9A:71.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_C_HCYC900_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 11 | ASN A 33LEU A 35GLN A 39TRP A 69MET A 70MET A 73ARG A 80THR A 208 | 1CA A 247 (-2.9A)1CA A 247 ( 4.4A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 (-3.8A)1CA A 247 (-3.4A) | 0.71A | 4p6xC-2q3yA:36.3 | 4p6xC-2q3yA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_C_HCYC900_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 11 | ASN A 33LEU A 35GLN A 39TRP A 69MET A 70MET A 73ARG A 80THR A 208 | 1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.5A)1CA A 249 (-3.2A) | 0.58A | 4p6xC-3ry9A:36.6 | 4p6xC-3ry9A:71.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | LEU A 32ASN A 33GLN A 39MET A 70MET A 73LEU A 77ARG A 80THR A 208PHE A 219 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.70A | 4p6xE-2q3yA:35.9 | 4p6xE-2q3yA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39MET A 70MET A 73LEU A 77ARG A 80THR A 208PHE A 219 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.58A | 4p6xE-3ry9A:36.0 | 4p6xE-3ry9A:71.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | ASN A 33GLN A 39TRP A 69MET A 70LEU A 77ARG A 80MET A 115THR A 208 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 (-3.4A) | 0.72A | 4p6xG-2q3yA:36.2 | 4p6xG-2q3yA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | ASN A 33GLN A 39TRP A 69MET A 70LEU A 77ARG A 80THR A 208PHE A 219 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.51A | 4p6xG-2q3yA:36.2 | 4p6xG-2q3yA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ASN A 33GLY A 37TRP A 69THR A 208PHE A 219 | 1CA A 247 (-2.9A)NoneNone1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.01A | 4p6xG-2q3yA:36.2 | 4p6xG-2q3yA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | ASN A 33GLY A 36GLN A 39TRP A 69MET A 70LEU A 77ARG A 80MET A 115THR A 208 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-3.2A) | 0.72A | 4p6xG-3ry9A:36.0 | 4p6xG-3ry9A:71.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | ASN A 33GLY A 36GLN A 39TRP A 69MET A 70LEU A 77ARG A 80THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.42A | 4p6xG-3ry9A:36.0 | 4p6xG-3ry9A:71.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | ASN A 33GLY A 37TRP A 69THR A 208PHE A 219 | 1CA A 249 (-3.0A)NoneNone1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.98A | 4p6xG-3ry9A:36.0 | 4p6xG-3ry9A:71.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | LEU A 32ASN A 33GLN A 39MET A 70LEU A 77ARG A 80MET A 115THR A 208 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 (-3.4A) | 0.76A | 4p6xI-2q3yA:36.2 | 4p6xI-2q3yA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | LEU A 32ASN A 33GLN A 39MET A 70LEU A 77ARG A 80THR A 208PHE A 219 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.60A | 4p6xI-2q3yA:36.2 | 4p6xI-2q3yA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 12 | ASN A 33GLY A 37GLN A 39MET A 70THR A 208PHE A 219 | 1CA A 249 (-3.0A)None1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.15A | 4p6xI-3ry9A:36.1 | 4p6xI-3ry9A:71.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 115THR A 208PHE A 219 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.76A | 4p6xI-3ry9A:36.1 | 4p6xI-3ry9A:71.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | ASN A 33GLN A 39TRP A 69MET A 70ARG A 80MET A 115PHE A 219 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 (-4.5A) | 0.76A | 4p6xK-2q3yA:36.4 | 4p6xK-2q3yA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 7 / 12 | ASN A 33GLN A 39TRP A 69MET A 70ARG A 80THR A 208PHE A 219 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.52A | 4p6xK-2q3yA:36.4 | 4p6xK-2q3yA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ASN A 33GLY A 37TRP A 69THR A 208PHE A 219 | 1CA A 247 (-2.9A)NoneNone1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.04A | 4p6xK-2q3yA:36.4 | 4p6xK-2q3yA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 115THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.78A | 4p6xK-3ry9A:36.6 | 4p6xK-3ry9A:71.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | ASN A 33GLY A 37TRP A 69THR A 208PHE A 219 | 1CA A 249 (-3.0A)NoneNone1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.98A | 4p6xK-3ry9A:36.6 | 4p6xK-3ry9A:71.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PXM_A_ESTA2000_1 (ESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 32LEU A 35ALA A 36LEU A 77ARG A 80 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 0.34A | 4pxmA-2q3yA:28.3 | 4pxmA-2q3yA:26.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 11 / 12 | LEU A 29ASN A 33ALA A 36GLN A 39MET A 70ARG A 80MET A 108MET A 115LEU A 201CYH A 205PHE A 219 | 1CA A 247 ( 3.6A)1CA A 247 (-2.9A)1CA A 247 (-3.6A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A)1CA A 247 (-4.5A) | 0.50A | 4udaA-2q3yA:38.8 | 4udaA-2q3yA:73.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 29ASN A 33GLN A 39MET A 70ARG A 80MET A 108MET A 115LEU A 201CYH A 205PHE A 219 | 1CA A 249 ( 3.8A)1CA A 249 (-3.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A)1CA A 249 (-4.3A) | 0.38A | 4udaA-3ry9A:38.2 | 4udaA-3ry9A:70.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 6 | LEU A 28PHE A 204THR A 208VAL A 217 | None1CA A 247 (-4.7A)1CA A 247 (-3.4A)None | 0.98A | 4udaA-2q3yA:38.8 | 4udaA-2q3yA:73.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 6 | LEU A 32TRP A 69LEU A 111PHE A 204THR A 208VAL A 217 | 1CA A 247 (-4.0A)NoneNone1CA A 247 (-4.7A)1CA A 247 (-3.4A)None | 0.48A | 4udaA-2q3yA:38.8 | 4udaA-2q3yA:73.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 6 | LEU A 28PHE A 204THR A 208VAL A 217 | None1CA A 249 (-4.8A)1CA A 249 (-3.2A)1CA A 249 (-4.9A) | 1.08A | 4udaA-3ry9A:38.2 | 4udaA-3ry9A:70.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 6 | LEU A 32TRP A 69LEU A 111PHE A 204THR A 208VAL A 217 | 1CA A 249 (-3.9A)NoneNone1CA A 249 (-4.8A)1CA A 249 (-3.2A)1CA A 249 (-4.9A) | 0.56A | 4udaA-3ry9A:38.2 | 4udaA-3ry9A:70.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ASN A 33GLY A 37TRP A 69THR A 208PHE A 219 | 1CA A 247 (-2.9A)NoneNone1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.03A | 4udcA-2q3yA:36.2 | 4udcA-2q3yA:58.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | LEU A 32ASN A 33GLN A 39TRP A 69MET A 70ARG A 80MET A 115THR A 208 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 ( 3.7A)1CA A 247 (-3.4A) | 0.69A | 4udcA-2q3yA:36.2 | 4udcA-2q3yA:58.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | LEU A 32ASN A 33GLN A 39TRP A 69MET A 70ARG A 80THR A 208PHE A 219 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 ( 3.8A)1CA A 247 (-3.8A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.60A | 4udcA-2q3yA:36.2 | 4udcA-2q3yA:58.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | ASN A 33GLY A 37TRP A 69THR A 208PHE A 219 | 1CA A 249 (-3.0A)NoneNone1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.00A | 4udcA-3ry9A:36.2 | 4udcA-3ry9A:71.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 115THR A 208PHE A 219 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.78A | 4udcA-3ry9A:36.2 | 4udcA-3ry9A:71.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35ALA A 36LEU A 77ARG A 80MET A 108 | 1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.83A | 4xi3C-2q3yA:25.0 | 4xi3C-2q3yA:27.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35ALA A 36TRP A 69LEU A 77ARG A 80 | 1CA A 247 ( 4.4A)1CA A 247 (-3.6A)None1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 0.61A | 4xi3C-2q3yA:25.0 | 4xi3C-2q3yA:27.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZN7_A_DESA601_1 (ESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 32ALA A 36LEU A 77ARG A 80MET A 108LEU A 223 | 1CA A 247 (-4.0A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A)None | 0.70A | 4zn7A-2q3yA:28.2 | 4zn7A-2q3yA:27.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZN7_A_DESA601_1 (ESTROGEN RECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 32LEU A 77ARG A 80MET A 108LEU A 223 | 1CA A 249 (-3.9A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)1CA A 249 (-3.6A)None | 0.65A | 4zn7A-3ry9A:27.8 | 4zn7A-3ry9A:29.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GS4_A_ESTA603_1 (ESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35ALA A 36LEU A 77ARG A 80MET A 108 | 1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.75A | 5gs4A-2q3yA:27.2 | 5gs4A-2q3yA:27.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GTR_A_ESTA601_1 (ESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | LEU A 35ALA A 36LEU A 77ARG A 80MET A 108 | 1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.75A | 5gtrA-2q3yA:27.1 | 5gtrA-2q3yA:27.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HYR_B_ESTB601_1 (ESTROGEN RECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 11 | LEU A 35ALA A 36LEU A 77ARG A 80MET A 108 | 1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)1CA A 247 (-3.9A) | 0.47A | 5hyrB-2q3yA:27.5 | 5hyrB-2q3yA:27.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_0 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | ALA A 36TRP A 69MET A 70LEU A 77MET A 115LEU A 201 | 1CA A 247 (-3.6A)None1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 ( 3.7A)1CA A 247 ( 4.2A) | 0.80A | 5mwyA-2q3yA:39.0 | 5mwyA-2q3yA:72.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_0 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | LEU A 29LEU A 32ASN A 33ALA A 36TRP A 69MET A 70LEU A 77MET A 108LEU A 201 | 1CA A 247 ( 3.6A)1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 (-3.6A)None1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.9A)1CA A 247 ( 4.2A) | 0.33A | 5mwyA-2q3yA:39.0 | 5mwyA-2q3yA:72.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_0 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 8 / 12 | LEU A 29LEU A 32ASN A 33TRP A 69MET A 70LEU A 77MET A 108LEU A 201 | 1CA A 249 ( 3.8A)1CA A 249 (-3.9A)1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A) | 0.34A | 5mwyA-3ry9A:38.3 | 5mwyA-3ry9A:59.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_0 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | TRP A 69MET A 70LEU A 77MET A 115LEU A 201 | None1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.6A)1CA A 249 ( 4.2A) | 0.86A | 5mwyA-3ry9A:38.3 | 5mwyA-3ry9A:59.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 6 | GLN A 39ARG A 80PHE A 92CYH A 205THR A 208PHE A 219 | 1CA A 247 (-3.1A)1CA A 247 (-3.8A)None1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.31A | 5mwyA-2q3yA:39.0 | 5mwyA-2q3yA:72.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_1 (MINERALOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 4 / 6 | PHE A 98CYH A 205THR A 208PHE A 219 | None1CA A 247 (-4.0A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.21A | 5mwyA-2q3yA:39.0 | 5mwyA-2q3yA:72.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 6 / 6 | GLN A 39ARG A 80PHE A 92CYH A 205THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 (-3.5A)None1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.29A | 5mwyA-3ry9A:38.1 | 5mwyA-3ry9A:59.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_1 (MINERALOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 4 / 6 | PHE A 98CYH A 205THR A 208PHE A 219 | None1CA A 249 (-4.0A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.33A | 5mwyA-3ry9A:38.1 | 5mwyA-3ry9A:59.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | ASN A 33GLN A 39MET A 70ARG A 80CYH A 112MET A 115THR A 208PHE A 219 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)1CA A 247 ( 3.8A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 0.67A | 5nfpA-2q3yA:36.6 | 5nfpA-2q3yA:58.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | ASN A 33GLY A 37MET A 70THR A 208PHE A 219 | 1CA A 247 (-2.9A)None1CA A 247 ( 3.8A)1CA A 247 (-3.4A)1CA A 247 (-4.5A) | 1.09A | 5nfpA-2q3yA:36.6 | 5nfpA-2q3yA:58.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | ASN A 33GLY A 36GLN A 39MET A 70ARG A 80CYH A 112MET A 115THR A 208PHE A 219 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)1CA A 249 ( 3.8A)1CA A 249 (-3.5A)None1CA A 249 (-3.6A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 0.61A | 5nfpA-3ry9A:36.6 | 5nfpA-3ry9A:66.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | ASN A 33GLY A 37MET A 70THR A 208PHE A 219 | 1CA A 249 (-3.0A)None1CA A 249 ( 3.8A)1CA A 249 (-3.2A)1CA A 249 (-4.3A) | 1.00A | 5nfpA-3ry9A:36.6 | 5nfpA-3ry9A:66.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TOA_A_ESTA601_1 (ESTROGEN RECEPTORBETA) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 6 / 12 | LEU A 32LEU A 35ALA A 36MET A 70LEU A 77ARG A 80 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)1CA A 247 (-3.6A)1CA A 247 ( 3.8A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A) | 0.27A | 5toaA-2q3yA:26.5 | 5toaA-2q3yA:29.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TOA_A_ESTA601_1 (ESTROGEN RECEPTORBETA) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 5 / 12 | LEU A 32LEU A 35MET A 70LEU A 77ARG A 80 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 ( 3.8A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A) | 0.27A | 5toaA-3ry9A:25.9 | 5toaA-3ry9A:29.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | LEU A 32LEU A 35GLY A 37GLN A 39MET A 73LEU A 77ARG A 80CYH A 112MET A 115 | 1CA A 247 (-4.0A)1CA A 247 ( 4.4A)None1CA A 247 (-3.1A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A) | 0.75A | 5uc1A-2q3yA:24.4 | 5uc1A-2q3yA:58.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | LEU A 35GLY A 37GLN A 39TRP A 69MET A 73LEU A 77ARG A 80CYH A 112MET A 115 | 1CA A 247 ( 4.4A)None1CA A 247 (-3.1A)None1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A) | 0.82A | 5uc1A-2q3yA:24.4 | 5uc1A-2q3yA:58.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 32LEU A 35GLY A 36GLY A 37GLN A 39MET A 73LEU A 77ARG A 80CYH A 112MET A 115 | 1CA A 249 (-3.9A)1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)None1CA A 249 (-3.0A)1CA A 249 (-3.9A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)None1CA A 249 (-3.6A) | 0.73A | 5uc1A-3ry9A:24.4 | 5uc1A-3ry9A:70.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | LEU A 35GLY A 36GLY A 37GLN A 39TRP A 69MET A 73LEU A 77ARG A 80CYH A 112MET A 115 | 1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)None1CA A 249 (-3.0A)None1CA A 249 (-3.9A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)None1CA A 249 (-3.6A) | 0.92A | 5uc1A-3ry9A:24.4 | 5uc1A-3ry9A:70.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 10 / 12 | LEU A 32ASN A 33LEU A 35GLY A 37GLN A 39MET A 73LEU A 77ARG A 80CYH A 112MET A 115 | 1CA A 247 (-4.0A)1CA A 247 (-2.9A)1CA A 247 ( 4.4A)None1CA A 247 (-3.1A)1CA A 247 (-3.6A)1CA A 247 ( 3.9A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A) | 0.81A | 5uc1B-2q3yA:24.5 | 5uc1B-2q3yA:58.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 11 / 12 | LEU A 32ASN A 33LEU A 35GLY A 36GLY A 37GLN A 39MET A 73LEU A 77ARG A 80CYH A 112MET A 115 | 1CA A 249 (-3.9A)1CA A 249 (-3.0A)1CA A 249 ( 4.4A)1CA A 249 ( 4.0A)None1CA A 249 (-3.0A)1CA A 249 (-3.9A)1CA A 249 ( 4.1A)1CA A 249 (-3.5A)None1CA A 249 (-3.6A) | 0.77A | 5uc1B-3ry9A:24.4 | 5uc1B-3ry9A:70.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 9 / 12 | ASN A 33GLN A 39TRP A 69MET A 73ARG A 80PHE A 92MET A 115LEU A 201CYH A 205 | 1CA A 247 (-2.9A)1CA A 247 (-3.1A)None1CA A 247 (-3.6A)1CA A 247 (-3.8A)None1CA A 247 ( 3.7A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A) | 0.57A | 5uc3A-2q3yA:31.6 | 5uc3A-2q3yA:58.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 10 / 12 | ASN A 33GLY A 36GLN A 39TRP A 69MET A 73ARG A 80PHE A 92MET A 115LEU A 201CYH A 205 | 1CA A 249 (-3.0A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 (-3.9A)1CA A 249 (-3.5A)None1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A) | 0.75A | 5uc3A-3ry9A:31.3 | 5uc3A-3ry9A:69.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 5 / 12 | GLN A 39VAL A 43PHE A 92MET A 115LEU A 201 | 1CA A 247 (-3.1A)NoneNone1CA A 247 ( 3.7A)1CA A 247 ( 4.2A) | 1.29A | 5uc3B-2q3yA:31.5 | 5uc3B-2q3yA:58.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
2q3y | ANCESTRAL CORTICIODRECEPTOR (unidentified) | 8 / 12 | LEU A 32GLN A 39TRP A 69ARG A 80PHE A 92MET A 115LEU A 201CYH A 205 | 1CA A 247 (-4.0A)1CA A 247 (-3.1A)None1CA A 247 (-3.8A)None1CA A 247 ( 3.7A)1CA A 247 ( 4.2A)1CA A 247 (-4.0A) | 0.54A | 5uc3B-2q3yA:31.5 | 5uc3B-2q3yA:58.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
3ry9 | ANCESTRALGLUCOCORTICOIDRECEPTOR 1 (syntheticconstruct) | 9 / 12 | LEU A 32GLY A 36GLN A 39TRP A 69ARG A 80PHE A 92MET A 115LEU A 201CYH A 205 | 1CA A 249 (-3.9A)1CA A 249 ( 4.0A)1CA A 249 (-3.0A)None1CA A 249 (-3.5A)None1CA A 249 (-3.6A)1CA A 249 ( 4.2A)1CA A 249 (-4.0A) | 0.72A | 5uc3B-3ry9A:31.0 | 5uc3B-3ry9A:69.23 |